On November 20, 2025, French scientists have made significant strides in exploring the potential of messenger RNA (mRNA) technology to combat cancer, particularly focusing on one of the most lethal forms: pancreatic cancer. This research is being conducted at the ART lab of the French research institute INSERM located in Orleans.

The Role of mRNA in Cancer Treatment

Messenger RNA plays a crucial role in biological processes by transporting genetic information from DNA to the cellular machinery responsible for protein synthesis. As explained by Dimitri Szymczak, project manager of the ART lab, "For cancer, this message will stimulate the patient's ability to effectively fight tumors." This innovative approach marks a departure from traditional cancer treatments, focusing instead on harnessing the body’s own immune system to tackle malignancies.

Historical Context and Current Research

While the discovery of mRNA dates back to the early 1960s, its prominence surged during the COVID-19 pandemic when it was utilized to produce next-generation vaccines, which earned a Nobel Prize in Medicine in 2023. Researchers are now pivoting from vaccine development to broader applications, including:

  • Boosting immunity
  • Compensating for malfunctioning cells
  • Targeting rare or genetic diseases
  • Treating allergies

According to Chantal Pichon, head of the ART lab, "There are more than 200 mRNA clinical trials being conducted by both big pharma and start-ups around the world," with significant activities concentrated in the United States, China, and Japan. However, she emphasizes that France has some of the best fundamental research teams dedicated to mRNA.

Innovative Production Techniques

One of the major challenges in the development of mRNA therapies is the cost associated with the production of the RNA molecules. Traditionally, RNA has been produced in test tubes, a method that is often patented by companies in the United States. The ART lab's researchers are investigating an alternative production method using yeast, which could reduce costs by an astounding 10 to 50 times.

Focus on Pancreatic Cancer

The ART lab is also at the forefront of research aimed at improving survival rates for patients with pancreatic cancer, which remains critically low despite advancements in treatment options. The survival rate has only seen a modest increase from 5% in 2000 to 10% today, highlighting the ineffectiveness of current therapies like chemotherapy and immunotherapy. Birane Beye, an ART gastroenterologist, states that these meager advancements necessitate a paradigm shift in treatment strategies.

Combining mRNA with Ultrasound Technology

In a pioneering effort, French scientists are exploring the combination of mRNA therapy with ultrasound technology to enhance treatment efficacy. The approach involves:

  1. Employing ultrasound to generate vibrations in the pancreatic tissue, causing gas bubbles to form.
  2. Utilizing the bursting of these bubbles to disrupt the protective barrier surrounding tumors—described as akin to a "bunker."
  3. Allowing the mRNA vaccine to penetrate the tumor effectively.

So far, initial results indicate that ultrasound can indeed be employed on the pancreas, improving outcomes when combined with traditional treatment methods.

Awareness and Future Directions

As Thursday marks World Pancreatic Cancer Day, this research underscores the urgent need for breakthroughs in combating this aggressive disease. The ART lab's ultimate goal is to significantly enhance the survival rates of pancreatic cancer patients through innovative uses of mRNA technology.

Conclusion

The ongoing research at the ART lab in Orleans is not only indicative of France's robust capabilities in fundamental scientific research but also promises to contribute substantially to the arsenal of tools available in the fight against one of the deadliest forms of cancer. The innovative blending of mRNA with ultrasound technology could revolutionize treatment paradigms, paving the way for new therapeutic strategies that harness the body’s immune potential in novel ways.

References

French scientists probe mRNA's potential to fight cancer (2025, November 20) retrieved from Medical Xpress